Most cited papers from APLA Health

APLA Health

What are the most cited papers from APLA Health?

The most cited paper from APLA Health is "SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease" (Loren Laine et al., 2015), with 776 citations. Next come "An Introduction to the Sport Commitment Model" (630) and "COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV" (496).

Published TypeFieldAccessCitations

Showing 50 of 59 papers. Every paper with more than 109 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease Loren Laine et al. · Gastroenterology Open access	20 Feb 2015	776
2	An Introduction to the Sport Commitment Model Tara Kost Scanlan, Paul J. Carpenter, Jeffery P. Simons et al. · Journal of Sport and Exercise Psychology	Mar 1993	630
3	COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV Laura M. Bogart, Bisola O. Ojikutu, Keshav Tyagi et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes Open access	16 Nov 2020	496
4	Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV cost and services utilization study Ron D. Hays, William E. Cunningham, Cathy Donald Sherbourne et al. · The American Journal of Medicine	Jun 2000	367
5	The Sport Commitment Model: Measurement Development for the Youth-Sport Domain Tara Kost Scanlan, Paul J. Carpenter, Jeffery P. Simons et al. · Journal of Sport and Exercise Psychology	Mar 1993	355
6	Sexual risk as an outcome of social oppression: Data from a probability sample of Latino gay men in three U.S. cities. Rafael M. Díaz, George Ayala, Edward Bein · Cultural Diversity & Ethnic Minority Psychology	Aug 2004	354
7	Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention Mary Glenn Fowler et al. · New England Journal of Medicine Open access	2 Nov 2016	351
8	A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors Philippe Lucien Bedard, Josep M. Tabernero, Filip Jankú et al. · Clinical Cancer Research Open access	11 Dec 2014	331
9	Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy Anna Galstyan et al. · Nature Communications Open access	28 Aug 2019	300
10	Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells Yoshimasa Saito, Peter M. Jones · Cell Cycle Open access	25 Sep 2006	275
11	Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells Ronald T. Mitsuyasu et al. · Nature Medicine Open access	15 Feb 2009	263
12	3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease Liana G. Apostolova, Ivo D. Dinov, Rebecca A. Dutton et al. · Brain Open access	29 Sep 2006	254
13	HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota Ian H. McHardy, Xiaoxiao Li, Maomeng Tong et al. · Microbiome Open access	12 Oct 2013	249
14	Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV-1 Infection Janis V. Giorgi, Robert H. Lyles, Jose L. Matud et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes	Apr 2002	245
15	The digital skin of cities: urban theory and research in the age of the sensored and metered city, ubiquitous computing and big data Chirag Rabari, Michael Storper · Cambridge Journal of Regions Economy and Society Open access	27 Oct 2014	237
16	Norepinephrine Accelerates HIV Replication Via Protein Kinase A-Dependent Effects on Cytokine Production Steve W. Cole, Yael D. Korin, John L. Fahey et al. · The Journal of Immunology	Jul 1998	231
17	Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. Jianhui Fan, Hong Z. Bass, James Liam Fahey · The Journal of Immunology	Nov 1993	215
18	Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial Jonathan G. Hiller, Steve W. Cole, Elizabeth M. Crone et al. · Clinical Cancer Research	21 Nov 2019	214
19	Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? H-H M Truong, Timothy Allen Kellogg, Jeffrey David Klausner et al. · Sexually Transmitted Infections Open access	24 May 2006	214
20	Sexual Risk Behaviors and Acceptability of HIV Pre-Exposure Prophylaxis Among HIV-Negative Gay and Bisexual Men in Serodiscordant Relationships: A Mixed Methods Study Ronald A. Brooks, Raphael J. Landovitz, Rachel L. Kaplan et al. · AIDS Patient Care and STDs Open access	7 Dec 2011	205
21	The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults J Michael Kilby, Jacob Paul Lalezari, Joseph J. Eron et al. · AIDS Research and Human Retroviruses	Jul 2002	200
22	Preventing HIV Among Latino and African American Gay and Bisexual Men in a Context of HIV-Related Stigma, Discrimination, and Homophobia: Perspectives of Providers Ronald A. Brooks, Mark A. Etzel, Ernesto Hinojos et al. · AIDS Patient Care and STDs Open access	Nov 2005	200
23	Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial Raphael J. Landovitz et al. · PLoS Medicine Open access	8 Nov 2018	178
24	Parentification and Its Impact on Adolescent Children of Parents with AIDS Judith A. Stein, Marion Riedel, Mary Jane Rotheram‐Borus · Family Process	Jun 1999	176
25	Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements John L. Fahey, Jeremy M. G. Taylor, Byomkesh Manna et al. · AIDS	Sep 1998	172
26	Characterization of cDNA clones for human myeloperoxidase: Predicted amino acid sequence and evidence for multiple mRNA species Keith Roberts Johnson, William Michael Nauseef, Alessandra Carè et al. · Nucleic Acids Research Open access	1987	168
27	Removing Barriers to Knowing HIV Status Stephen F. Morin, Gertrude N. Khumalo-Sakutukwa, Edwin D. Charlebois et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes	4 Jan 2006	167
28	Brief Report: PrEP Uptake, Adherence, and Discontinuation Among California YMSM Using Geosocial Networking Applications Ian W. Holloway, Ryan J. Dougherty, Jennifer L. Gildner et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes Open access	23 Aug 2016	161
29	Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration Duo Xu et al. · Advanced Materials	24 May 2019	159
30	Association Between Direct Measures of Body Composition and Prognostic Factors in Chronic Heart Failure Antigone Oreopoulos, Justin Adrian Ezekowitz, Finlay Aleck McAlister et al. · Mayo Clinic Proceedings Open access	30 Jun 2010	158
31	Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma Mark J. Roschewski et al. · Journal of Clinical Oncology Open access	26 May 2020	156
32	Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection Alexander N. Freiberg, Melissa N. Worthy, Benhur Lee et al. · Journal of General Virology Open access	4 Nov 2009	155
33	HIV Prevention With Mexican Migrants Kurt C. Organista, Héctor Gabriel Díaz Carrillo, George Ayala · JAIDS Journal of Acquired Immune Deficiency Syndromes	19 Oct 2004	155
34	Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa Risa M. Hoffman, Vivian Black, Karl‐Günter Technau et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes Open access	18 Mar 2010	152
35	Risk Factors for Sudden Infant Death Syndrome in the US Collaborative Perinatal Project Jess F. Kraus, Sander Greenland, Marc Bulterys · International Journal of Epidemiology	1989	150
36	A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy Jacob Paul Lalezari, Joseph J. Eron, Margrit Carlson et al. · AIDS	Mar 2003	150
37	Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships Ronald A. Brooks, Rachel L. Kaplan, Eli Lieber et al. · AIDS Care Open access	5 Apr 2011	150
38	A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System Di Wu, Meng Qin, Duo Xu et al. · Advanced Materials Open access	25 Feb 2019	144
39	Dissemination as Dialogue: Building Trust and Sharing Research Findings Through Community Engagement Bryce McDavitt, Laura M. Bogart, Matt G. Mutchler et al. · Preventing Chronic Disease Open access	11 Mar 2016	144
40	Prevention, treatment and cure of HIV infection Raphael J. Landovitz, Hyman M Scott, Steven G. Deeks · Nature Reviews Microbiology Review	21 Jun 2023	143
41	A Test of the Sport Commitment Model Using Structural Equation Modeling Paul J. Carpenter, Tara Kost Scanlan, Jeffery P. Simons et al. · Journal of Sport and Exercise Psychology	Jun 1993	140
42	Rapid Serologic Testing with Immune-Complex-Dissociated HIV p24 Antigen for Early Detection of HIV Infection in Neonates Steven A. Miles, Erin Balden, Larry I. Magpantay et al. · New England Journal of Medicine Open access	4 Feb 1993	140
43	Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group Denis R. Miller, S. Leikin, Vincent C. Albo et al. · Cancer Open access	15 Mar 1983	139
44	Anti-Human Immunodeficiency Virus Hematopoietic Progenitor Cell-Delivered Ribozyme in a Phase I Study: Myeloid and Lymphoid Reconstitution in Human Immunodeficiency Virus Type-1–Infected Patients Rafael G. Amado, Ronald T. Mitsuyasu, Joseph D. Rosenblatt et al. · Human Gene Therapy	Mar 2004	136
45	Progression of carotid artery intima–media thickening in HIV-infected and uninfected adults Judith S. Currier, Michelle A. Kendall, W. Keith Henry et al. · AIDS	11 May 2007	135
46	Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 Mark A. Marzinke et al. · The Journal of Infectious Diseases Open access	18 Mar 2021	134
47	The Politics of Precarity Ching Kwan Lee, Yelizavetta Kofman · Work and Occupations	24 Oct 2012	130
48	Prevention for Substance-Using HIV-Positive Young People Mary Jane Rotheram‐Borus, Dallas T. Swendeman, Warren Scott Comulada et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes Open access	22 Sep 2004	130
49	ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI Elizabeth Robins Gerstner, Zheng Zhang, James R. Fink et al. · Clinical Cancer Research Open access	16 May 2016	122
50	COVID-19 Vaccine Intentions and Mistrust in a National Sample of Black Americans Laura M. Bogart, Lu Dong, Priya Gandhi et al. · Journal of the National Medical Association Open access	20 Jun 2021	121

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.